Edesa Biotech Inc.

NASDAQ: EDSA · Real-Time Price · USD
2.24
-0.02 (-0.88%)
At close: Aug 15, 2025, 3:59 PM
2.23
-0.22%
After-hours: Aug 15, 2025, 04:04 PM EDT

Edesa Biotech Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Cash & Equivalents
13.9M 1.56M 1.04M 2.04M 2.8M 4.27M 5.36M 6.46M 7.47M 8.27M 7.09M 12.81M 15.89M 5.88M 7.84M 8.05M 10.97M 6.31M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -500K n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a -233K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
38.75K 38.7K 41.15K 40.66K 41.07K 177.73K 173.49K 177.82K 174.13K 173.89K 171.46K 0.00 0.00 -0.00 -0.00 n/a -0.00 -0.00
Receivables
382.44K 350.64K 270.91K 551.06K 1.11M 743.57K 626.54K 42.87K 50.23K 125.48K 1.26M 1.4M 1.25M 2.88M 3.3M 4.19M 7.81M 168.03K
Inventory
n/a n/a n/a n/a n/a n/a -1.08M n/a n/a -125.48K n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
108.2K 157.79K 367.39K 454.69K 330.27K 404.9K 448.91K 414.05K 608.11K 690.95K 745.54K 968.06K n/a 1.13M n/a 2.1M 2.64M 1.19M
Total Current Assets
14.39M 2.07M 1.68M 3.05M 4.24M 5.42M 6.44M 6.91M 8.13M 9.09M 9.09M 15.18M 18M 9.89M 12.09M 14.33M 21.42M 7.67M
Property-Plant & Equipment
n/a n/a 18.36K 36.29K 62.34K 83.07K 100.08K 122.31K 139.16K 158.34K 31.16K 54.28K 75.96K 94.49K 111.56K 135.38K 150.38K 165.2K
Goodwill & Intangibles
2.03M 2.05M 2.08M 2.1M 2.13M 2.15M 2.18M 2.21M 2.23M 2.26M 2.28M 2.31M 2.33M 2.36M 2.38M 2.41M 2.43M 2.46M
Total Long-Term Assets
2.07M 2.09M 2.14M 2.18M 2.23M 2.42M 2.45M 2.51M 2.54M 2.59M 2.48M 2.36M 2.41M 2.45M 2.49M 2.54M 2.58M 2.62M
Total Assets
16.45M 4.16M 3.81M 5.23M 6.48M 7.83M 8.89M 9.42M 10.67M 11.67M 11.58M 17.54M 20.41M 12.34M 14.58M 16.88M 24M 10.29M
Account Payables
n/a n/a n/a 2.32M 2.09M 1.91K 1.75K 1.45K 1.5K 1.21K 2.12M 5.62M 3.27M 1.67M 1.38M 903.96K 4.54M 831.45
Deferred Revenue
n/a n/a n/a n/a -2.09M -1.91K -1.75K -1.45K -1.5K -1.21K -2.12M -5.62M -3.27M -1.67M -1.38M -903.96K -4.54M -831.45
Short-Term Debt
n/a n/a n/a n/a n/a 78.31K 74.71K 74.85K n/a 69.91K 18.98K n/a n/a 80.17K n/a n/a 77.01K n/a
Other Current Liabilities
914.7K 1.9M 1.81M n/a n/a 1.83M 1.67M 1.38M 1.5M 1.14M -18.98K n/a n/a -80.17K n/a n/a -77.01K 830.62K
Total Current Liabilities
914.7K 1.9M 1.83M 2.36M 2.15M 1.99M 1.82M 1.53M 1.56M 1.28M 2.14M 5.66M 3.34M 1.75M 1.46M 983.47K 4.62M 906.33K
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a 44.34K 44.28K 43.66K 46.54K 47.97K 47.24K 47.2K 48.4K 47.65K 1.42M
Total Long-Term Liabilities
n/a n/a n/a n/a n/a n/a 19.77K 40.08K 108.76K 120.9K 43.66K 46.54K 47.97K 47.24K 67.71K 90.12K 108.77K 1.5M
Total Liabilities
914.7K 1.9M 1.83M 2.36M 2.15M 1.99M 1.84M 1.57M 1.67M 1.4M 2.18M 5.7M 3.38M 1.79M 1.53M 1.07M 4.73M 2.41M
Total Debt
n/a n/a 19.87K 38.82K 58.14K 78.31K 94.49K 114.92K 129.83K 146.53K 18.98K 40.12K 61.54K 80.17K 99.32K 121.23K 138.14K 154.8K
Common Stock
54.27M 47.56M 47.24M 47.24M 47.14M 46.93M 46.64M 46.14M 45.45M 44.47M 42.47M 40.26M 40.26M 36.12M 34.89M 34.63M 34.6M 21.7M
Retained Earnings
-61.86M -60.23M -58.59M -57.63M -55.96M -54.1M -52.42M -50.7M -48.71M -46.38M -44.04M -41.23M -35.44M -30.87M -26.5M -22.81M -18.05M -15.78M
Comprehensive Income
-287.69K -223.96K -242.61K -224.79K -226.4K -215.22K -214.65K -190.19K -230.03K -238.67K -213.6K -125.79K -160.35K -173.41K -205.26K -20.13K -194.26K -183.78K
Shareholders Equity
15.54M 2.26M 1.98M 2.87M 4.32M 5.84M 7.05M 7.85M 9M 10.27M 9.39M 11.84M 17.02M 10.55M 13.06M 15.8M 19.27M 7.89M
Total Investments
n/a n/a n/a n/a n/a n/a -233K n/a n/a n/a n/a n/a n/a n/a -500K n/a n/a n/a